O	0	10	Randomized
B-intervention	11	19	exercise
I-intervention	20	25	trial
O	26	28	of
O	29	38	aromatase
O	39	48	inhibitor
O	48	49	-
O	49	56	induced
O	57	67	arthralgia
O	68	70	in
O	71	77	breast
O	78	84	cancer
O	85	94	survivors
O	94	95	.

O	96	106	Arthralgia
O	107	113	occurs
O	114	116	in
O	117	119	up
O	120	122	to
O	123	125	50
O	125	126	%
O	127	129	of
O	130	136	breast
O	137	143	cancer
O	144	153	survivors
O	154	161	treated
O	162	166	with
O	167	176	aromatase
O	177	187	inhibitors
O	188	189	(
O	189	192	AIs
O	192	193	)
O	194	197	and
O	198	200	is
O	201	204	the
O	205	209	most
O	210	216	common
O	217	223	reason
O	224	227	for
O	228	232	poor
O	233	235	AI
O	236	245	adherence
O	245	246	.

O	247	249	We
O	250	259	conducted
O	259	260	,
O	261	263	in
B-total-participants	264	267	121
O	268	274	breast
O	275	281	cancer
O	282	291	survivors
O	292	301	receiving
O	302	304	an
O	305	307	AI
O	308	311	and
O	312	321	reporting
O	322	332	arthralgia
O	332	333	,
O	334	335	a
O	336	344	yearlong
O	345	355	randomized
O	356	361	trial
O	362	364	of
O	365	368	the
O	369	375	impact
O	376	378	of
O	379	387	exercise
O	388	394	versus
O	395	400	usual
O	401	405	care
O	406	408	on
O	409	419	arthralgia
O	420	428	severity
O	428	429	.

O	430	441	Eligibility
O	442	450	criteria
O	451	459	included
O	460	469	receiving
O	470	472	an
O	473	475	AI
O	476	479	for
O	480	482	at
O	483	488	least
O	489	490	6
O	491	497	months
O	497	498	,
O	499	508	reporting
O	509	510	≥
O	511	512	3
O	513	515	of
O	516	518	10
O	519	522	for
O	523	528	worst
O	529	534	joint
O	535	539	pain
O	540	542	on
O	543	546	the
O	547	552	Brief
O	553	557	Pain
O	558	567	Inventory
O	568	569	(
O	569	572	BPI
O	572	573	)
O	573	574	,
O	575	578	and
O	579	588	reporting
O	589	590	<
O	591	593	90
O	594	601	minutes
O	602	605	per
O	606	610	week
O	611	613	of
O	614	621	aerobic
O	622	630	exercise
O	631	634	and
O	635	637	no
O	638	646	strength
O	647	655	training
O	655	656	.

O	657	669	Participants
O	670	674	were
O	675	683	randomly
O	684	692	assigned
O	693	695	to
O	696	704	exercise
O	705	706	(
O	706	709	150
O	710	717	minutes
O	718	721	per
O	722	726	week
O	727	729	of
O	730	737	aerobic
O	738	746	exercise
O	747	750	and
O	751	761	supervised
O	762	770	strength
O	771	779	training
O	780	785	twice
O	786	789	per
O	790	794	week
O	794	795	)
O	796	798	or
B-control	799	804	usual
I-control	805	809	care
O	809	810	.

O	811	814	The
B-outcome-Measure	815	818	BPI
O	818	819	,
B-outcome-Measure	820	827	Western
I-outcome-Measure	828	835	Ontario
I-outcome-Measure	836	839	and
I-outcome-Measure	840	848	McMaster
I-outcome-Measure	849	861	Universities
I-outcome-Measure	862	876	Osteoarthritis
I-outcome-Measure	877	878	(
I-outcome-Measure	878	883	WOMAC
I-outcome-Measure	883	884	)
I-outcome-Measure	885	890	index
O	890	891	,
O	892	895	and
B-outcome-Measure	896	908	Disabilities
I-outcome-Measure	909	911	of
I-outcome-Measure	912	915	the
I-outcome-Measure	916	919	Arm
I-outcome-Measure	919	920	,
I-outcome-Measure	921	929	Shoulder
I-outcome-Measure	930	933	and
I-outcome-Measure	934	938	Hand
I-outcome-Measure	939	940	(
I-outcome-Measure	940	944	DASH
I-outcome-Measure	944	945	)
I-outcome-Measure	946	959	questionnaire
O	960	964	were
O	965	974	completed
O	975	977	at
O	978	986	baseline
O	987	990	and
O	991	993	at
O	994	995	3
O	995	996	,
O	997	998	6
O	998	999	,
O	1000	1001	9
O	1001	1002	,
O	1003	1006	and
O	1007	1009	12
O	1010	1016	months
O	1016	1017	.

O	1018	1030	Intervention
O	1031	1038	effects
O	1039	1043	were
O	1044	1053	evaluated
O	1054	1059	using
O	1060	1065	mixed
O	1065	1066	-
O	1066	1071	model
O	1072	1080	repeated
O	1081	1089	measures
O	1090	1098	analysis
O	1098	1099	,
O	1100	1104	with
O	1105	1111	change
O	1112	1114	at
O	1115	1117	12
O	1118	1124	months
O	1125	1127	as
O	1128	1131	the
O	1132	1139	primary
O	1140	1143	end
O	1144	1149	point
O	1149	1150	.

O	1151	1155	Over
O	1156	1158	12
O	1159	1165	months
O	1165	1166	,
O	1167	1172	women
O	1173	1181	randomly
O	1182	1190	assigned
O	1191	1193	to
O	1194	1202	exercise
O	1203	1204	(
O	1204	1205	n
O	1206	1207	=
B-intervention-participants	1208	1210	61
O	1210	1211	)
B-outcome	1212	1220	attended
B-iv-bin-percent	1221	1223	70
I-iv-bin-percent	1223	1224	%
O	1225	1226	(
O	1226	1227	±
O	1228	1236	standard
O	1237	1246	deviation
O	1247	1248	[
O	1248	1250	SD
O	1250	1251	]
O	1251	1252	,
O	1253	1255	28
O	1255	1256	%
O	1256	1257	)
O	1258	1260	of
O	1261	1271	resistance
O	1272	1280	training
O	1281	1289	sessions
O	1290	1293	and
B-outcome	1294	1303	increased
I-outcome	1304	1309	their
I-outcome	1310	1318	exercise
O	1319	1321	by
B-iv-cont-mean	1322	1325	159
O	1326	1327	(
O	1327	1328	±
O	1329	1331	SD
O	1331	1332	,
B-iv-cont-sd	1333	1336	136
O	1336	1337	)
O	1338	1345	minutes
O	1346	1349	per
O	1350	1354	week
O	1354	1355	.

O	1356	1361	Worst
B-outcome	1362	1367	joint
I-outcome	1368	1372	pain
I-outcome	1373	1379	scores
O	1380	1389	decreased
O	1390	1392	by
B-iv-cont-mean	1393	1394	1
I-iv-cont-mean	1394	1395	.
I-iv-cont-mean	1395	1396	6
I-iv-cont-mean	1397	1403	points
O	1404	1405	(
O	1405	1407	29
O	1407	1408	%
O	1408	1409	)
O	1410	1412	at
O	1413	1415	12
O	1416	1422	months
O	1423	1428	among
O	1429	1434	women
O	1435	1443	randomly
O	1444	1452	assigned
O	1453	1455	to
O	1456	1464	exercise
O	1465	1471	versus
O	1472	1473	a
B-cv-cont-mean	1474	1475	0
I-cv-cont-mean	1475	1476	.
I-cv-cont-mean	1476	1477	2
I-cv-cont-mean	1477	1478	-
I-cv-cont-mean	1478	1483	point
O	1484	1492	increase
O	1493	1494	(
O	1494	1495	3
O	1495	1496	%
O	1496	1497	)
O	1498	1503	among
O	1504	1509	those
O	1510	1519	receiving
O	1520	1525	usual
O	1526	1530	care
O	1531	1532	(
O	1532	1533	n
O	1534	1535	=
O	1536	1538	60
O	1538	1539	;
O	1540	1541	P
O	1542	1543	<
O	1544	1545	.
O	1545	1548	001
O	1548	1549	)
O	1549	1550	.

B-outcome	1551	1555	Pain
I-outcome	1556	1564	severity
I-outcome	1565	1568	and
I-outcome	1569	1581	interference
O	1581	1582	,
O	1583	1585	as
O	1586	1590	well
O	1591	1593	as
B-outcome	1594	1598	DASH
I-outcome	1599	1602	and
I-outcome	1603	1608	WOMAC
I-outcome	1609	1613	pain
I-outcome	1614	1620	scores
O	1620	1621	,
O	1622	1626	also
O	1627	1636	decreased
O	1637	1650	significantly
O	1651	1653	at
O	1654	1656	12
O	1657	1663	months
O	1664	1666	in
O	1667	1672	women
O	1673	1681	randomly
O	1682	1690	assigned
O	1691	1693	to
O	1694	1702	exercise
O	1702	1703	,
O	1704	1712	compared
O	1713	1717	with
O	1718	1727	increases
O	1728	1731	for
O	1732	1737	those
O	1738	1747	receiving
O	1748	1753	usual
O	1754	1758	care
O	1759	1760	(
O	1760	1763	all
O	1764	1765	P
O	1766	1767	<
O	1768	1769	.
O	1769	1772	001
O	1772	1773	)
O	1773	1774	.

O	1775	1783	Exercise
O	1784	1787	led
O	1788	1790	to
O	1791	1802	improvement
O	1803	1805	in
O	1806	1808	AI
O	1808	1809	-
O	1809	1816	induced
O	1817	1827	arthralgia
O	1828	1830	in
O	1831	1841	previously
O	1842	1850	inactive
O	1851	1857	breast
O	1858	1864	cancer
O	1865	1874	survivors
O	1874	1875	.
